UBS Group’s Synovus SNV Stock Holding History

UBS Group’s Portfolio SNV Stock Details SNV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,700	Closed	-$133K	–	11106
2025 Q3	$133K	Buy	+2,700	New	+$138K	﹤0.01%	6934
2025 Q2	–	Sell	-5,200	Closed	-$243K	–	10796
2025 Q1	$243K	Buy	+5,200	New	+$268K	﹤0.01%	6405

Other funds holding SNV

WBWA

William B. Walkup & Associates Columbia, South Carolina $167M AUM 20.75% 1-Year Est. Return

UBS Group's SNV Position: Q1 2026 in Review

UBS Group sold out of Synovus (SNV) in Q1 2026, closing a stake of 250,249 shares — an estimated $12.5M sold.

UBS Group first reported a position in SNV in Q4 2014 and held it in 45 quarters. The position peaked at $64.1M in Q1 2025. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

UBS Group reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
UBS Group sold 250,249 Synovus shares in Q1 2026, an estimated $12.5M.
UBS Group first reported a position in Synovus in Q4 2014 and held it in 45 quarters.
UBS Group's Synovus position peaked at $64.1M in Q1 2025.
1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.